Activation of Th1 Immunity Within the Tumor Microenvironment is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia($)

Immune stimulation contributes to lenalidomide’s anti-tumor activity. Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of mature, autoreactive B cells in secondary lymphoid tissues, blood and bone marrow and progressive immune dysfunction. Previous studies in CLL indicated tha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol
Main Authors: Aue, Georg, Sun, Clare, Liu, Delong, Park, Jae-Hyun, Pittaluga, Stefania, Tian, Xin, Lee, Elinor, Soto, Susan, Valdez, Janet, Maric, Irina, Stetler-Stevenson, Maryalice, Yuan, Constance, Nakamura, Yusuke, Muranski, Pawel, Wiestner, Adrian
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143435/
https://ncbi.nlm.nih.gov/pubmed/30104242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1800570
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados